CCL17 / CCR4 Axis Promotes Hematoma Clearance via ERK / AP1 / SRA ‐Mediated Microglial Polarization After Intracerebral Hemorrhage
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70288 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Xianglan Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, HuaShan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Receptors, CCR4, Cerebral Hemorrhage, Microglia, Chemokine CCL17. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Our previous studies demonstrated that CCL17 and its receptor CCR4 play crucial roles in neuroinflammation and microglial activation following intracerebral hemorrhage (ICH). However, the specific mechanisms by which the CCL17/CCR4 axis regulates microglial polarization and hematoma clearance remain unclear.
Aims
This study investigates how the CCL17/CCR4 signaling pathway modulates microglial phenotype transition and enhances hematoma resolution after ICH, building upon our earlier findings showing CCR4's involvement in neuroinflammatory responses.
Methods
Using CRISPR‐mediated CCR4 disruption and CCR4 overexpression approaches in a mouse ICH model, we examined neurological outcomes, inflammatory responses, and hematoma volumes. We further evaluated the therapeutic potential of recombinant CCL17 administration. The downstream ERK signaling pathway's role in CCL17/CCR4‐mediated microglial function was investigated through pharmacological inhibition.
Results
CCR4 knockout exacerbated neurological deficits, increased neuroinflammation, and enlarged hematomas. In contrast, enhancing CCR4 expression or administering recombinant CCL17 improved functional recovery and provided neuroprotection. Mechanistically, CCL17/CCR4 signaling activated the ERK/AP1/SRA pathway, promoting anti‐inflammatory, phagocytic microglial polarization, evidenced by increased CD206 and SRA expression. ERK inhibition reversed these protective effects.
Conclusion
Our findings extend previous work by revealing that the CCL17/CCR4 axis enhances hematoma clearance through the ERK/AP1/SRA pathway‐mediated microglial polarization. This mechanism represents a promising therapeutic target for ICH treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, HuaShan Hospital, Fudan University, Shanghai, China.
- Department of Intensive Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
ORCID-Profile: Shuixiang Deng
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Chen, X., Wang, Y., Jin, J., Jin, P., & Deng, S. (2025). CCL17 / CCR4 Axis Promotes Hematoma Clearance via ERK / AP1 / SRA ‐Mediated Microglial Polarization After Intracerebral Hemorrhage. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70288
Vancouver
Chen X, Wang Y, Jin J, Jin P, Deng S. CCL17 / CCR4 Axis Promotes Hematoma Clearance via ERK / AP1 / SRA ‐Mediated Microglial Polarization After Intracerebral Hemorrhage. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70288
BibTeX
@article{Chen2025,
author = {Chen, Xianglan and Wang, Yao and Jin, Junjie and Jin, Peng and Deng, Shuixiang},
title = {CCL17 / CCR4 Axis Promotes Hematoma Clearance via ERK / AP1 / SRA ‐Mediated Microglial Polarization After Intracerebral Hemorrhage},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70288}
}
EUVIMED